• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Philips adds cloud-based AI, 3D mapping to its image-guided therapy system

Philips adds cloud-based AI, 3D mapping to its image-guided therapy system

January 18, 2022 By Sean Whooley

Philips Zenition mobile c-arm
[Image from Philips]
Royal Philips (NYSE:PHG) announced today that it expanded the capabilities for its Zenition image-guided therapy mobile C-arm system.

Amsterdam-based Philips signed a strategic partnership with UK-based Cydar — a provider of cloud-based procedure maps software for planning and guiding surgery in real-time. The partnership will help enhance Zenition’s clinical accuracy and efficiency and improve outcomes for patients undergoing endovascular treatment.

Philips said in a news release that the Zenition mobile C-arm system combines image capture, processing, ease-of-use and versatility to maximize operating room performance. At the same time, the integration of Cydar EV Maps software into the platform will add extended procedure planning and real-time 3D guidance capabilities.

Cydar’s EV Maps assists in planning, real-time guidance and post-procedure review for endovascular surgery. The goal is to bring cloud-based AI and computer vision to mobile surgery to reduce radiation exposure, fluoroscopy time and procedure time. Surgeons using Cydar’s platform can create a detailed, patient-specific 3D map of the target vasculature to help plan surgery. They can then augment intraoperative live image guidance, updating the maps in real-time.

The platform from Cydar is currently in use across the U.S., UK and European Union as certified software-as-a-medical-device with CE mark and FDA 510(k) clearance.

“With Philips’ integrated portfolio, using validated AI and cloud technologies, we can facilitate collaborative care to optimize surgical pathways,” Philips GM of Image-Guided Therapy Systems Karim Boussebaa said in the release. “Philips has a strong global network of mobile surgery systems and recognizes that Cydar’s EV Maps solution can play a key role in further improving our integrated offering for endovascular procedures.”

Filed Under: Business/Financial News, Featured, Health Technology, Imaging, News Well, Software / IT, Surgical Tagged With: Cydar EV, Philips

More recent news

  • Leading medical device experts and MDO launch Medtech Innovation Board
  • Mitria Medical teams with Silicon Valley incubator for mitral repair device
  • Truvian links with Siemens Healthineers to advance benchtop blood testing
  • Medtronic snags breakthrough designation for below-the-knee drug-coated balloon
  • Abbott rolls out SimpleScreen colorectal cancer blood test developed by Freenome

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy